BBCIC Resources
Resources that support BBCIC’s effort to engage data consortium, managed care specialty drug experts, researchers, and industry to monitor biosimilars.
Statements
Arthritis:
- BBCIC public statement:
BBCIC presents a public statement at the February 9 FDA Arthritis Advisory Committee
Bernadette Eichelberger, PharmD
2016 February 9
Videos, Podcasts, and Articles
- "Not So Different": How the BPCIA Transition Will Affect Biosimilar Uptake
Published: Apr 09, 2020 - Trust, Planning Key to a Successful Biosimilar Launch, Panelists Say
Published: Jan 24, 2020 by Tony Hagen - Cate Lockhart, PharmD, PhD: Upcoming Research From the BBCIC
Published: Jan 14, 2020 - Cate Lockhart, PharmD, PhD: Challenges With Large-Scale Comparative Effectiveness Research
Published: Nov 22, 2019 - Cate Lockhart, PharmD, PhD: Forming the BBCIC
Published: Jul 23, 2018 - Cate Lockhart, PharmD, PhD: Biosimilar vs Generic Markets
Published: Jul 10, 2018 - Cate Lockhart, PharmD, PhD: Patient Acceptance of Biosimilars
Published: Jul 04, 2018 - Cate Lockhard, PharmD, PhD: Biosimilars and Price Competition
Published: Jun 27, 2018 - Cate Lockhart, PharmD, PhD: Similarities Between Biosimilars and Generics
Published: Jun 25, 2018 - BBCIC Seeks to Provide Stakeholders With Real-World Data on Biosimilars
Published: May 24, 2018 by Kelly Davio
Webinars
Data Consortiums
- AMCP webinar:
Biosimilars Surveillance: Applying the Science of Proven Data Consortium Models
Jeff Brown, PhD
2014 March 10
Additional Resources
Data Consortiums
- JMCP Biosimilar Task Force report:
Utilizing Data Consortia to Monitor Safety and Effectiveness of Biosimilars and Their Innovator Products
AMCP Task Force on Biosimilar Collective Intelligence Systems
2015 January
Sentinel Initiative
- Sentinel Initiative Public Workshop
Brookings Institute Engelberg Center for Health Care Reform
2015 February 5